《《《《《《《《内容已删除》》》》》》》》》

CBLB502

CBLB502

CBLB502

CBLB502

1

Given these promising results , it seems likely that clinical trials of CBLB502 will be undertaken in cancer patients soon .

考虑到这些充满前景的结果，CBLB502 在肿瘤患者中的临床试验将很快实施。

2

CBLB502 is a polypeptide drug derived from a portion of Salmonella flagellin that binds to and potently activates TLR5.

CBLB502 是一种多肽药物，它来源于沙门氏菌鞭毛蛋白的一部分，结合并有效地激活 TLR5 。

热词推荐

大家在看